This round-up covers new developments in China's infant formula market, SAMR's proposal to distinguish solid beverages from infant formula, and BY-HEALTH's plans in expanding its presence in Asia-Pacific.
China vitamin and dietary supplement (VDS) firm BY-HEALTH says the country’s health foods market is increasingly diverging between either foods/snacks with ‘light’ functionalities or supplements with ‘strong’ functionalities, as it unveiled 15% revenue...
China’s nutraceutical firm BY-HEALTH is funding new research that studies women’s and infant health, including the impact of probiotics on the gut microbiome and immune system in young children between one to three years old.
China’s homegrown nutraceutical brand BY-HEALTH smashed sales records under the health and nutrition category across Alibaba-owned Tmall and JD.com during the double 11 Singles’ Day annual shopping event.
BY-HEALTH has refreshed its brand logo and product packaging in a bid to revitalise its vitamins and dietary supplements (VDS) business, at the same time as reporting disappointing revenue figures for the first quarter of the year.
Chinese health foods giant BY-HEALTH's FY19 revenue jumped 20.94% to hit RMB$5.2bn (US$748m), however performance from its Australian subsidiary Life-Space failed to meet expectations due to changes in China’s e-commerce law.